Vident Investment Advisory’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,537	Closed	-$736K	–	1194
2023 Q1	$736K	Buy	1,537 +391	+34%	+$183K	0.02%	625
2022 Q4	$482K	Buy	1,146 +196	+21%	+$79.1K	0.02%	733
2022 Q3	$362K	Buy	950 +324	+52%	+$162K	0.01%	853
2022 Q2	$301K	Sell	626 -1,662	-73%	-$866K	0.01%	1011
2022 Q1	$1.29M	Buy	2,288 +327	+17%	+$197K	0.03%	606
2021 Q4	$1.48M	Buy	1,961 +789	+67%	+$590K	0.04%	577
2021 Q3	$874K	Buy	1,172 +75	+7%	+$56.2K	0.03%	725
2021 Q2	$708K	Sell	1,097 -67	-6%	-$40.8K	0.02%	748
2021 Q1	$665K	Buy	1,164 +59	+5%	+$34.9K	0.02%	712
2020 Q4	$645K	Buy	1,105 +12	+1%	+$6.83K	0.03%	648
2020 Q3	$563K	Sell	1,093 -83	-7%	-$42K	0.03%	638
2020 Q2	$531K	Buy	+1,176	New	+$519K	0.03%	628
2015 Q4	–	Sell	-6,378	Closed	-$857K	–	427
2015 Q3	$857K	Buy	+6,378	New	+$918K	0.12%	242